Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 November 2025 | Story Tshepo Tsotetsi | Photo Stephen Collett
Economist of the Year
Reatile Seekoei (centre), UFS’s 2025 Economist of the Year, with representatives from Sanlam and Santam.

University of the Free State (UFS) BCom Finance student Reatile Seekoei has again claimed the top prize in the UFS’s second annual Economist of the Year competition.

The event, hosted on 31 October 2025 by the Department of Economics and Finance in the Faculty of Economic and Management Sciences (EMS), brought together UFS students, academics, and parents at the Bloemfontein Campus to celebrate emerging talent in the field. The group was joined by sponsors from Sanlam and Santam.

The competition has quickly become a highlight on the academic calendar, offering students an opportunity to bridge classroom theory with real-world practice. It challenges them to apply their understanding of economic trends, policy analysis, and data interpretation to forecast future developments, helping them grow from students into confident, career-ready economists. The event also recognised the top-performing students in the department – from first-year level to master’s – in celebration of academic excellence.

 

Turning theory into practice

According to Prof Johan Coetzee, Head of the Department of Economics and Finance, the competition aims to give students a platform to apply what they learn in class to real-world scenarios. “The purpose of it is to expose students to macroeconomic indicators and to apply their forecasting skills,” he explained. “It forces students to read up on the news, to know what’s happening in the world around them, and to articulate their understanding clearly. In a world increasingly driven by AI, we need humans – we need economists – to set the narrative. This prepares them for the world of work.”

Prof Coetzee added that the judging focuses on both technical and communication skills, with 40% of the score based on forecasting accuracy and 60% on presentation and articulation. “Economists must not only understand the numbers, but also communicate what those numbers mean,” he said.

 

From conceptual thinker to confident economist

For Seekoei, winning the competition again was both a challenge and a statement of growth.

“I came into this competition for the second time with one goal: to defend my title,” he said. “To win again is thrilling because I had to deliver more than I did last year. It pushed me to grow from a more conceptualised economist into a mature one who can apply indicators and present economically well.”

His presentation impressed the judges with its structured approach. Seekoei built a framework that combined a baseline analysis of South Africa’s economy with an interpretation of leading indicators, inflation trends and monetary-policy direction. He credited his success to the guidance of his lecturers and his belief in self-discipline. “The key to my success is believing in myself,” he said. “It was me against myself. I had to deliver better than what I did last year, and that confidence made all the difference.”

The competition also saw outstanding performances from other finalists, including BCom student Malek Suhail as the first runner-up and BCom Law student Lunghile Rivombo as the second runner-up, both of whom impressed the judges and their peers with their analytical skill and innovative approach – a testament to the faculty’s interdisciplinary strength.

Prof Coetzee expressed gratitude to Sanlam and Santam for sponsoring the competition and helping to make the initiative possible. Their support, he noted, plays a vital role in nurturing future economists who are both analytically strong and socially aware.

As the department looks ahead to next year’s competition, Seekoei’s back-to-back wins set a new benchmark – one that will no doubt inspire his peers to challenge themselves, think critically, and forecast with both precision and passion.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept